BMS353 Haematology 2 (6)

This subject provides an in-depth study of advanced haematological concepts in areas of blood cell kinetics and regulation of cell cycle, haemopoietic malignancies, anaemias, and disorders of haemostatic systems (primary haemostasis, coagulation system and fibrinolytic system). Furthermore, quality control and quality assurance measures related to haematology are integrated into this subject.

No offerings have been identified for this subject in 2021.

Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System

HD/FL

Duration

One session

School

School of Biomedical Sciences

Prerequisites

BMS251 and BMS252

Subject Relationships

BMS306 BMS353 plus BMS354 Practical Haematology 2 is equivalent to BMS306

Incompatible Subjects

BMS306

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to explain the pathogenesis, clinical features, classification, laboratory diagnosis, and principles of treatment of haemopoietic malignancies;
  • be able to explain the pathogenesis, clinical findings, laboratory diagnosis and treatment of anaemias;
  • be able to explain the pathogenesis, classification, clinical features, laboratory diagnosis, and treatment of disorders of the haemostatic system;
  • be able to analyse the current impact of advances in molecular techniques relevant to haematology;
  • be able to analyse, interpret and apply the results of haematological tests, as well as some clinical findings, to problem-solving activities including but not limited to case studies in regard to haematological disorders;
  • be able to evaluate the key issues regarding quality control and quality assurance in the haematology laboratory; and
  • be able to demonstrate high levels of academic literacy.

Syllabus

This subject will cover the following topics:
  • MODULE 1: BLOOD CELL DYNAMICS AND HAEMATOLOGICAL MALIGNANCY
  • Introduction to oncogenesis of haematological malignancies;
  • Myeloproliferative neoplasms and myelodysplastic syndromes;
  • Acute leukaemias;
  • Mature lymphoid neoplasms; and
  • Laboratory investigation of haematological malignancies.
  • MODULE 2: HAEMOLYTIC ANAEMIA
  • Introduction to haemolytic anaemia;
  • Haemolytic anaemias due to intrinsic defects of the erythrocytes;
  • Extrinsic defects leading to increased erthrocyte destruction - Nonimmune causes;
  • Extrinsic defects leading to increased erthrocyte destruction - Immune causes;
  • Haemoglobinopathies; and
  • Thalassaemias.
  • MODULE 3: DISORDERS OF THE HAEMOSTATIC SYSTEM
  • Haemorrhagic disorders;
  • Thrombotic disorders;
  • Quantitative and qualitative platelet disorders; and
  • Laboratory investigation and management of haemostatic problems.
  • MODULE 4: QUALITY ASSURANCE AND AUTOMATION IN THE HAEMATOLOGY LABORATORY
  • Basic concepts of quality assurance;
  • Quality assurance in haematology; and
  • Automation in haematology.

The information contained in the CSU Handbook was accurate at the date of publication: May 2021. The University reserves the right to vary the information at any time without notice.

Back